Federation Des Caisses Desjardins Du Quebec Axogen, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Aug 30, 2024	SELL	$17.18 - $22.6 $4,724 - $6,215	-275 Closed	0 $0
Q4 2019 Aug 30, 2024	BUY	$11.18 - $18.6 $3,074 - $5,115	275 New	275 $4.92 Million

Others Institutions Holding AXGN

# of Institutions

163

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

First Light Asset Management, LLC Edina, MN

4.09M
Shares

$51.7 Million
5.0% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$41.1 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.01M
Shares

$38 Million
3.58% of portfolio
Morgan Stanley New York, NY

2.9M
Shares

$36.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.43M
Shares

$30.7 Million
0.0% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $534M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account